Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension.
Journal: EClinicalMedicine
Published: April 05, 2024
Factors influencing the indication of coronary angiography in patients presenting with chest pain unspecified: an analysis of two decades (1994-2014).
Journal: International journal for quality in health care : journal of the International Society for Quality in Health Care
Published: December 23, 2023
Hexasodium fytate exposure-response correlations in a randomized, placebo-controlled study of patients on dialysis with cardiovascular calcification.
Journal: Frontiers in pharmacology
Published: October 24, 2023
Analyzing long-term water quality of lakes in Rhode Island and the northeastern United States with an anomaly approach.
Journal: Ecosphere (Washington, D.C)
Published: July 12, 2021
The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis.
Journal: Clinical kidney journal
Published: April 06, 2021
Author Correction: A novel assay to measure calcification propensity: from laboratory to humans.
Journal: Scientific reports
Published: February 17, 2021
Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis: An Analysis of the Randomized, Placebo-Controlled CaLIPSO Study.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: October 28, 2020
Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis - Subgroup Analyses of the CALIPSO Trial.
Journal: Kidney international reports
Published: July 22, 2020
Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis.
Journal: British journal of pharmacology
Published: January 14, 2020
A novel assay to measure calcification propensity: from laboratory to humans.
Journal: Scientific reports
Published: November 12, 2019
Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis: Results of a Randomized Phase 2b Study.
Journal: Circulation
Published: November 12, 2019
Trial design and baseline characteristics of CaLIPSO: a randomized, double-blind placebo-controlled trial of SNF472 in patients receiving haemodialysis with cardiovascular calcification.
Journal: Clinical kidney journal
Published: July 22, 2019
Last Updated: 09/26/2026